EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Global Status of Adult Immunization Post COVID-19 Pandemic

Alba Vilajeliu, Victor Vega iD, Randie Gibson, Francisco Nogareda iD, Xiaojun Wang, Donald J Brooks iD, Charles Shey Wiysonge iD, Osman Niyazi Cakmak, Osama Mere iD, Melanie Marti iD, Phillip Lambach iD, Stephanie Shendale iD und 5 weitere

Vaccines · 11.04.2025 · 13 (4) · 401

DOI: 10.3390/vaccines13040401 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Vaccines, online erschienen am 11.04.2025. Verfasst von Alba Vilajeliu und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunization, Vaccines and Biologicals (IVB), World Health Organization, 1211 Geneva, Switzerland. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: World Health Organization.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objective: Historically, immunization programs have focused on infants, children, and women of reproductive age. COVID-19 vaccination prompted countries to vaccinate adults. The objective of this manuscript is to provide a global overview of adult immunization policies post COVID-19 pandemic.

Methods

We summarized WHO Strategic Advisory Group of Experts on Immunization (SAGE) recommendations by adult group and analyzed the data reported in 2024 (2023) by WHO Member States (MS) via the WHO/UNICEF electronic Joint Reporting Form on Immunization (eJRF) on national immunization schedules, and from other sources by WHO region and income group.

Results

WHO policy recommendations exist for most of the licensed vaccines targeting adults; however, the inclusion in national immunization schedules is higher in high-income (HICs) and middle-income (MICs) countries. For pregnant women, 90% of MS reported vaccination against COVID-19 (65% in low-income countries [LICs]), 63% against tetanus-containing vaccines (73% in LICs), 57% against influenza (4% in LICs), and 21% against pertussis-containing vaccines (all MICs and HICs). For health workers, 91% against COVID-19 (92% in LICs), 59% against influenza (4% in LICs), and 25% against hepatitis B (10% in LICs). For adults with chronic diseases, COVID-19 vaccination data were not available, 58% against influenza, and 23% against pneumococcal disease. For older adults, more than 90% of MS across all income groups reported COVID-19 vaccination, 59% against influenza (8% of LICs versus 89% of HICs), 17% against pneumococcal, and 7% against herpes zoster (HZ).

Conclusion

The disparities in adult immunization policies across income groups highlight the need to improve access and strengthen vaccination efforts. A life course approach is essential to maximize the full potential of immunization across all ages.

Schlagwörter

Stichwörter der Autor:innen

adultchronic diseaseselderlyhealth workersimmunizationpregnant women

Autor:innen und Institutionen

  • Department of Immunization, Vaccines and Biologicals (IVB), World Health Organization, 1211 Geneva, Switzerland.
  • Special Program Comprehensive Immunization, Pan American Health Organization (PAHO)/World Health Organization Regional Office for the Americas, Washington, DC 20037, USA.
  • Vaccine-Preventable Diseases and Immunization Unit, Division of Programmes for Disease Control, World Health Organization, Regional Office for Western Pacific, Manila 1000, Philippines.
  • Department of Epidemic and Pandemic Threat Management, World Health Organization, 1211 Geneva, Switzerland.
  • Vaccine-Preventable Diseases Programme, World Health Organization, Regional Office for Africa, Brazzaville P.O. Box 06, Congo.
  • Vaccine-Preventable Diseases and Immunization Programme, World Health Organization, Regional Office for Europe, 2100 Copenhagen, Denmark.

ORCID-Profile: Victor Vega, Francisco Nogareda, Donald J Brooks, Charles Shey Wiysonge, Osama Mere, Melanie Marti, Phillip Lambach, Stephanie Shendale, Emmanuel Njambe, Erin Grace Sparrow, Joachim Hombach, Ann Lindstrand

Förderung

  • World Health Organization

Zitieren

APA

Vilajeliu, A., Vega, V., Gibson, R., Nogareda, F., Wang, X., Brooks, D. J., Wiysonge, C. S., Cakmak, O. N., Mere, O., Marti, M., Lambach, P., Shendale, S., Contreras, M., Njambe, E., Sparrow, E. G., Hombach, J., & Lindstrand, A. (2025). Global Status of Adult Immunization Post COVID-19 Pandemic. Vaccines, 13(4), 401. https://doi.org/10.3390/vaccines13040401

Vancouver

Vilajeliu A, Vega V, Gibson R, Nogareda F, Wang X, Brooks DJ, et al. Global Status of Adult Immunization Post COVID-19 Pandemic. Vaccines. 2025;13(4):401. doi:10.3390/vaccines13040401

BibTeX
@article{Vilajeliu2025,
  author = {Vilajeliu, Alba and Vega, Victor and Gibson, Randie and Nogareda, Francisco and Wang, Xiaojun and Brooks, Donald J and Wiysonge, Charles Shey and Cakmak, Osman Niyazi and Mere, Osama and Marti, Melanie and Lambach, Phillip and Shendale, Stephanie and Contreras, Marcela and Njambe, Emmanuel and Sparrow, Erin Grace and Hombach, Joachim and Lindstrand, Ann},
  title = {Global Status of Adult Immunization Post COVID-19 Pandemic},
  journal = {Vaccines},
  year = {2025},
  volume = {13},
  number = {4},
  pages = {401},
  doi = {10.3390/vaccines13040401}
}
Kostenlos starten →